American Origin Unverified
This profile is unclaimed and has not been independently reviewed.
Claim & get verified
Inhibitor Therapeutics, Inc.
$0.08
+10.21%
OTC: INTI · 15-min delayed
$0Revenue · FY2021
-$3.3MNet income
INTIOTC
About Inhibitor Therapeutics, Inc.
INHIBITOR THERAPTICS INC
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Reported figures
Financial summary
- Revenue FY2021
- $0
- Net income
- -$3.3M
- Total assets
- $2.5M
Source: SEC EDGAR · updated Jun 7, 2026
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Market data by Polygon.io · prices are 15-minute delayed
Auto-generated
At a glance
- Reported a net loss of $3.3M in FY2021.
- Trading 33% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Inhibitor Therapeutics, Inc..
Write a review
Newsroom
News about Inhibitor Therapeutics, Inc.
News & sentiment via Polygon.io
Explore
Browse all →
